DICLOFENAC DUO PHARMASWISS
75MG CPS DUR MRL 30 I
| SÚKL code | 0119672 |
|---|---|
| Name of the product | DICLOFENAC DUO PHARMASWISS |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | DICLOFENAC DUO PHARMASWISS |
| Supplement | 75MG CPS DUR MRL 30 I |
| Strenght | 75MG |
| Pharmaceutical form | Modified-release capsule, hard |
| Package | 30 I |
| Route | Oral use |
| Language of the pack | Czech |
| Wrap type | Blister |
| Legal status | na lékařský předpis |
| Active substance | DICLOFENAC SODIUM (DICLOFENACUM NATRICUM) |
| ATC group | M01AB05 |
| ATC group name | DIKLOFENAK |
Marketing authorisation information
| Registration Number | 29/ 967/95-C |
|---|---|
| Type of MA | National |
| MA status | B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till) |
| Placed on the market till | 31. 07. 2020 |
| MA Holder | PharmaSwiss Česká republika s.r.o., Praha |
| MA Holder country | ČESKÁ REPUBLIKA |
| Actual MA holder | Bausch Health Ireland Limited, Dublin |
| Actual MA holder country | IRSKO |
cz